Novartis Pharma US

          Advice From the Experts

After conducting large studies of patients with high cholesterol, health experts concluded that as cholesterol levels rise, an increase in the risk for heart disease follows. When cholesterol is lowered, the risk is lowered.

THE EXPERTS' ADVISE: Start with a healthy diet and regular exercise. Always consult your doctor before beginning any diet or exercise program.


In July 2004, the National Cholesterol Education Program (NCEP) updated their Adult Treatment Panel (ATP) III guidelines with evidence taken from recent statin trials. The revised guidelines suggest even more intensive cholesterol treatment for people at moderately high or high risk for the most serious cardiac complications, such as heart attack or dying from coronary heart disease.

Clinical trials support lower target LDL-C in select patient populations.

Different risk categories require different treatment depending on their LDL number.

Framingham Risk Calculator
A risk assessment tool is available that predicts a person’s chance of having a heart attack in the next 10 years. This tool uses information based on the Framingham Heart Study, a study conducted under the National Heart, Lung, and Blood Institute (NHLBI).
Click here to access a 10-year risk calculator at www.nhlbi.nih.gov/guidelines/cholesterol.


For high risk patients
Cholesterol medication should be taken if LDL is 100 mg/dL or over1
 
For moderately high-risk patients
Cholesterol medication should be taken if LDL is 130 mg/dL or over1
 
For moderate-risk patients
Moderate risk patients should have an LDL goal of <130 mg/dL and should take cholesterol medication when LDL is ≥ 160 mg/dL1
 
For low-risk patients
Low-risk patients should have an LDL goal of 160 mg/dL or less1
 
LESCOL® XL taken just once a day can help you get to your cholesterol goal with proven tolerability.
Learn more about heart disease and cholesterol


Reference:
1.Grundy SM, Cleeman JI, Merz CNB, et al, for the Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227-239.

 
LESCOL® XL Home  |  Join The XL Everyday Program  |  About LESCOL® XL
For LESCOL® XL Patients  |  About Cholesterol  |  Why Treat High Cholesterol
How to Lower Your Cholesterol  |  A Wealth of Health Online
Patient Product Information  |  Healthcare Professional


Contact Us |  Site Map |  Site Guide
Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ©2010
Novartis Pharmaceuticals Corporation. All rights reserved.

Novartis proudly supports the Together Rx Access program.
Together Rx Access